Elmiron lawsuits are civil cases filed by people who took Elmiron and later suffered maculopathy or other major eyesight disorders. Janssen Pharmaceuticals allegedly knew about the potential of eye injury but failed to sufficiently notify the public, according to Elmiron lawsuits.
Maculopathy, retinopathy and other vision problems
Janssen Pharmaceuticals, subsidiary of Johnson & Johnson
Beginning stages of litigation
- Blurred vision
- Degenerative maculopathy
- Halo vision
- Macular retinopathy
- Macular/pattern dystrophy
- Maculopathy
- Metamorphopsia
- Pigmentary maculopathy
- Reduced night vision
- Retinal pigment epithelium atrophy
- Retinopathy
- Scotoma
- Unilateral or bilateral blindness
- Vision impairment
- Vision loss
Lawyers are considering lawsuits from persons who used Elmiron for at least two years and developed visual difficulties, particularly if they took it from 2018 to the present.
These vision impairments have to have started while you were using Elmiron or within a year of stopping it. If you stopped using Elmiron in 2010 and were diagnosed with an eye problem in 2011, you might be eligible.
Free Case Review
When you contact a lawyer about a prospective Elmiron vision injury case, they may inquire about your personal experiences with the medicine. Make sure you include as much information as possible while answering questions.
Case Review Form
